StemInov
1 known investors
StemInov is a biotech developing WhartSep, an off-the-shelf stem cell therapy derived from umbilical cord (Wharton's jelly) cells with three complementary actions to treat severe pneumonia and sepsis. The company targets immune disorders and tissue repair as unmet medical needs.
BiotechHealthtechMedical Devices
Founders & leadership
JH
Julie HutinCEO & Co-founder
DB
Danièle BensoussanCSO & Co-founder
PC
PE CharlesClinical Strategy
CD
Claude DedryCMC
Investors · 1
Frequently asked questions
- What does StemInov do?
- StemInov is a biotech developing WhartSep, an off-the-shelf stem cell therapy derived from umbilical cord (Wharton's jelly) cells with three complementary actions to treat severe pneumonia and sepsis. The company targets immune disorders and tissue repair as unmet medical needs.
- Who are StemInov's investors?
- StemInov's investors include Angels Santé.